应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MDCO 麦迪逊医药
停牌 01-03 16:00:00 EST
84.90
+0.00
0.00%
最高
84.90
最低
84.90
成交量
0.00
今开
84.90
昨收
84.90
日振幅
0.00%
总市值
67.88亿
流通市值
63.56亿
总股本
7,995万
成交额
0.00
换手率
0.00%
流通股本
7,486万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
革命药物2024年第四季度GAAP每股收益$(1.12)不及$(1.00)的预期
财报速递 · 02-26
革命药物2024年第四季度GAAP每股收益$(1.12)不及$(1.00)的预期
Cencora 第一季度财报：肥胖药物和特殊药品推动收入和每股收益超预期
财报速递 · 02-05
Cencora 第一季度财报：肥胖药物和特殊药品推动收入和每股收益超预期
加载更多
公司概况
公司名称：
麦迪逊医药
所属市场：
NASDAQ
上市日期：
--
主营业务：
Medicines specializes in acute care hospital products and also acquires, develops and commercializes pharmaceutical products in late stages of their development.
发行价格：
--
{"stockData":{"symbol":"MDCO","market":"US","secType":"STK","nameCN":"麦迪逊医药","latestPrice":84.9,"timestamp":1578085200000,"preClose":84.9,"halted":3,"volume":0,"delay":0,"floatShares":74862655,"shares":79948329,"eps":-3.137449,"marketStatus":"停牌","change":0,"latestTime":"01-03 16:00:00 EST","open":84.9,"high":84.9,"low":84.9,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.137449,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754035200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":965707200000,"exchange":"NASDAQ","adjPreClose":84.9,"volumeRatio":0},"requestUrl":"/m/hq/s/MDCO","defaultTab":"news","newsList":[{"id":"1156518576","title":"革命药物2024年第四季度GAAP每股收益$(1.12)不及$(1.00)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1156518576","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156518576?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:34","pubTimestamp":1740605690,"startTime":"0","endTime":"0","summary":"革命药物公司报告季度亏损为每股$，比分析师共识估计的$低12%。这相比去年同期每股$的亏损有所减少，减少了1.75%。以上内容来自Benzinga Earnings专栏，原文如下：Revolution Medicines reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 12 percent. This is a 1.75 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCO","RVMD"],"gpt_icon":0},{"id":"1126125390","title":"Cencora 第一季度财报：肥胖药物和特殊药品推动收入和每股收益超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1126125390","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126125390?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:11","pubTimestamp":1738771872,"startTime":"0","endTime":"0","summary":"周三，Cencora, Inc公布其2025财年第一季度销售额增长12.8%，达到815亿美元，超过市场预期的783.8亿美元。公司报告的调整后每股收益为3.73美元，同比增长13.7%，超过市场预期的3.50美元。调整后的毛利润在2025年第一季度为25亿美元，比上一财年同期增长6.1%，这是由于两个报告部门的毛利润增加。Cencora预期调整后的摊薄每股收益为15.25至15.55美元，高于1月2日提供的15.15至15.45美元的范围以及最初的14.80至15.10美元的范围，市场预期为15.28美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCO","COR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.themedicinescompany.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.1153},{"period":"6month","weight":0.0503},{"period":"1year","weight":0.1475},{"period":"ytd","weight":0.0785}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Medicines specializes in acute care hospital products and also acquires, develops and commercializes pharmaceutical products in late stages of their development.","exchange":"NASDAQ","name":"麦迪逊医药","nameEN":"Medicines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"麦迪逊医药(MDCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供麦迪逊医药(MDCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"麦迪逊医药,MDCO,麦迪逊医药股票,麦迪逊医药股票老虎,麦迪逊医药股票老虎国际,麦迪逊医药行情,麦迪逊医药股票行情,麦迪逊医药股价,麦迪逊医药股市,麦迪逊医药股票价格,麦迪逊医药股票交易,麦迪逊医药股票购买,麦迪逊医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"麦迪逊医药(MDCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供麦迪逊医药(MDCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}